Universitätsklinikum Ulm

Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025) Walter CB, Hartkopf AD, Hein A, Fasching P, Kolberg HC, Hadji P, Tesch H, et al. Journal article Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis (2025) Outla Z, Oyman-Eyrilmez G, Korelova K, Prechova M, Frick L, Sarnova L, Bisht P, et al. Journal article Versatile Features of an Antibody Mimetic Peptide and Its Variants (2025) Dolles S, Leukel S, Gensberger-Reigl S, Rohrhofer A, Rauch-Wirth L, Kaygisiz K, Synatschke C, et al. Journal article Endovascular management of haemorrhage and vascular lesions in patients with multiple and/or severe injuries: a systematic review and clinical practice guideline update (2025) Wagner HJ, Goossen K, Hilbert-Carius P, Braunschweig R, Kildal D, Hinck D, Albrecht T, Könsgen N Journal article, Review article Psychological, neuroendocrine and inflammatory stress responses in women after miscarriage or stillbirth: investigating early psychobiological adaptations to potential traumatic events (2025) Gerber L, Müller MM, Oender A, Urbanczyk S, Radermacher P, Brucker C, Stein B, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025 (2025) Thill M, Janni W, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 (2025) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article Therapy of early breast cancer: current status and perspectives (2025) Tauber N, Amann N, Dannehl D, Deutsch TM, Dimpfl M, Fasching P, Hartkopf A, et al. Journal article, Review article COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study (2025) Pixberg C, Maurer C, Smetanay K, Straβl L, Hlevnjak M, Zapatka M, Wagner CV, et al. Journal article Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer (2025) Lüftner D, Banys-Paluchowski M, Hartkopf AD, Hörner M, Janni W, Langanke D, Müller V, et al. Journal article